Abstract
The immunogenicity and tolerability of hepatitis A virus vaccine was evaluated in a group of 32 children with human immunodeficiency virus (HIV) infection and 27 children with seroreversion. After 2 doses of vaccine, 100% of children experienced seroconversion with good toleration of the vaccine. There were no differences in variation of virus load between immunized HIV-positive children and a group of 31 nonimmunized HIV-positive children with similar characteristics. © 2005 by the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Gouvea, A. F. T. B., De Moraes-Pinto, M. I., Ono, E., Dinelli, M. I. S., Machado, D. M., Weckx, L. Y., & Succi, R. C. M. (2005). Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children. Clinical Infectious Diseases, 41(4), 544–548. https://doi.org/10.1086/432055
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
